Enterprise Bank & Trust Co Cuts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Enterprise Bank & Trust Co decreased its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 7.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,671 shares of the healthcare conglomerate’s stock after selling 793 shares during the period. UnitedHealth Group comprises 1.9% of Enterprise Bank & Trust Co’s investment portfolio, making the stock its 12th biggest position. Enterprise Bank & Trust Co’s holdings in UnitedHealth Group were worth $4,932,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Palisades Hudson Asset Management L.P. raised its stake in UnitedHealth Group by 2.0% during the fourth quarter. Palisades Hudson Asset Management L.P. now owns 1,078 shares of the healthcare conglomerate’s stock worth $542,000 after purchasing an additional 21 shares during the period. Charter Oak Capital Management LLC raised its stake in UnitedHealth Group by 2.4% during the fourth quarter. Charter Oak Capital Management LLC now owns 881 shares of the healthcare conglomerate’s stock worth $442,000 after purchasing an additional 21 shares during the period. Oxford Financial Group Ltd. raised its stake in UnitedHealth Group by 3.0% during the fourth quarter. Oxford Financial Group Ltd. now owns 720 shares of the healthcare conglomerate’s stock worth $362,000 after purchasing an additional 21 shares during the period. Griffin Asset Management Inc. raised its stake in UnitedHealth Group by 0.3% during the first quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock worth $3,414,000 after purchasing an additional 21 shares during the period. Finally, Donald L. Hagan LLC boosted its position in shares of UnitedHealth Group by 1.2% during the 4th quarter. Donald L. Hagan LLC now owns 1,854 shares of the healthcare conglomerate’s stock worth $931,000 after purchasing an additional 22 shares during the period. Institutional investors and hedge funds own 87.48% of the company’s stock.

In related news, Director Frederick William Mcnabb III purchased 89 shares of the firm’s stock in a transaction that occurred on Thursday, May 26th. The stock was acquired at an average cost of $504.32 per share, for a total transaction of $44,884.48. Following the completion of the acquisition, the director now owns 11,259 shares in the company, valued at approximately $5,678,138.88. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the transaction, the director now directly owns 1,215,000 shares in the company, valued at approximately $581,936,400. The disclosure for this sale can be found here. 0.40% of the stock is owned by company insiders.

A number of research firms recently weighed in on UNH. Oppenheimer increased their price objective on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a research report on Monday, April 18th. Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective for the company. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $570.00 to $577.00 and gave the stock an “overweight” rating in a research report on Monday, April 18th. Truist Financial raised their price target on shares of UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Finally, Loop Capital began coverage on shares of UnitedHealth Group in a research report on Thursday, June 16th. They issued a “buy” rating and a $575.00 price target for the company. Three equities research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $555.73.

Shares of NYSE UNH opened at $489.68 on Thursday. The firm’s 50-day moving average is $496.56 and its two-hundred day moving average is $490.86. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.78 and a quick ratio of 0.78. The company has a market capitalization of $459.40 billion, a PE ratio of 26.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.83. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.40 by $0.09. The company had revenue of $80.15 billion during the quarter, compared to analyst estimates of $78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The business’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.31 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 21.75 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 28th. Stockholders of record on Monday, June 20th will be given a $1.65 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date of this dividend is Thursday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.12%.

UnitedHealth Group Company Profile (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.